Skip to product information
1 of 7

PayPal, credit cards. Download editable-PDF and invoice in 1 second!

GB/T 42502-2023 English PDF (GBT42502-2023)

GB/T 42502-2023 English PDF (GBT42502-2023)

Regular price $185.00 USD
Regular price Sale price $185.00 USD
Sale Sold out
Shipping calculated at checkout.
Quotation: In 1-minute, 24-hr self-service. Click here GB/T 42502-2023 to get it for Purchase Approval, Bank TT...

GB/T 42502-2023: Specification for auditing quality management of pharmaceutical logistics

This document stipulates the basic requirements for pharmaceutical logistics quality management auditors, audit work requirements, as well as audit content, audit judgment, audit results and feedback, and evaluation and improvement requirements. This document is applicable for auditing pharmaceutical logistics service providers by pharmaceutical logistics quality management auditors.
GB/T 42502-2023
GB
NATIONAL STANDARD OF THE
PEOPLE REPUBLIC OF CHINA
ICS 03.120.10
CCS A 00
Specification for auditing quality management of
pharmaceutical logistics
ISSUED ON: MARCH 17, 2023
IMPLEMENTED ON: MARCH 17, 2023
Issued by: State Administration for Market Regulation;
Standardization Administration of PRC.
Table of Contents
Foreword ... 3
1 Scope ... 5
2 Normative references ... 5
3 Terms and definitions ... 5
4 Basic requirements for auditors ... 6
5 Audit work requirements ... 6
6 Audit content ... 7
7 Audit judgment ... 11
8 Audit results and feedback ... 11
9 Evaluation and improvement ... 11
References ... 13
Specification for auditing quality management of
pharmaceutical logistics
1 Scope
This document stipulates the basic requirements for pharmaceutical logistics quality management auditors, audit work requirements, as well as audit content, audit judgment, audit results and feedback, and evaluation and improvement requirements. This document is applicable for auditing pharmaceutical logistics service providers by pharmaceutical logistics quality management auditors.
2 Normative references
The following documents contain the provisions which, through normative reference in this document, constitute the essential provisions of this document. For the dated referenced documents, only the versions with the indicated dates are applicable to this document; for the undated referenced documents, only the latest version (including all the amendments) is applicable to this document.
GB/T 28842 Operation specifications for medicinal product cold chain logistics GB/T 30335 Service specification of drug logistic
GB/T 34399 Temperature control facilities of pharmaceutical products cold chain logistics - Specification for performance qualification
GB/T 35145 Cold chain temperature logger
JT/T 1325 Technical specification and test method for travelling temperature recorder
WB/T 1097 General specification for cold-chain insulated container of drug WB/T 1104 Road transport - Requirements of refrigerated vehicle functions for pharmaceutical products
3 Terms and definitions
The following terms and definitions apply to this document.
3.1 audit
The process in which the pharmaceutical logistics quality management auditor checks to determine whether the quality management of pharmaceutical logistics service providers meets the audit content and forms documents.
[Source: GB/T 19011-2021, 3.1, modified]
3.2 pharmaceutical logistics quality management auditor
A legal person organization that implements pharmaceutical logistics quality management audit work.
NOTE: It includes pharmaceutical logistics service entrusting parties, quality management full-time audit institutions, etc.
4 Basic requirements for auditors
4.1 An audit management system of pharmaceutical logistics quality management shall be established.
4.2 Quality management personnel with quality management audit capabilities shall be had.
4.3 The audit materials and related information provided by the pharmaceutical logistics service provider shall be kept confidential.
5 Audit work requirements
5.1 The pharmaceutical logistics service entrusting party shall audit the service quality management and other aspects of the pharmaceutical logistics service provider when they cooperate for the first time, during the cooperation period, and when the pharmaceutical logistics service provider undergoes major changes. The frequency of audits during the cooperation period shall comply with relevant regulations. 5.2 The corresponding service quality management audit work plan shall be formulated according to the business model of the pharmaceutical logistics service provider and the types of business it undertakes, and the audit work plan shall be informed to the pharmaceutical logistics service provider in advance.
5.3 The audit work plan shall include but is not limited to the name of the pharmaceutical logistics service provider, audit time, audit location, audit type and method, audit purpose, audit basis, audit scope, audit team members, audit implementation process, audit content, and the list of audit materials required to be and improved for suitability and effectiveness.
6.2.3 For personnel and training, the following contents shall be audited. a) The suitability of the staffing to the type of business to be undertaken. Whether the personnel in the key positions have no experience of job forbidden. NOTE: Personnel in key positions include quality management personnel, personnel in positions directly in contact with drugs, etc.
b) Whether the relevant operators of cold chain drugs have passed the assessment before starting to work. Whether transport drivers and forklift operators have obtained certificates for operations.
c) The pre-employment and annual health checks of personnel directly in contact with pharmaceuticals, and the establishment of employee health management files. Whether the person suffering from an infectious disease or other diseases that may contaminate the drug is not engaged in work that directly contacts the drug.
d) The formulation and approval of the annual training plan and whether the training is carried out according to the plan.
e) Implementation of pre-employment and regular training for personnel in each position in terms of job responsibilities and job content; whether the training contents include but are not limited to laws and regulations, professional knowledge, job responsibilities, etc.
f) Whether the training archives include training records, photos, videos, assessment materials, and other documents.
6.2.4 For facilities and equipment, the warehouses, vehicles, refrigerators or incubators, temperature recorders, information systems, etc. shall be audited, and the specific requirements are as follows.
a) For the warehouse, the following contents shall be audited:
1) Whether the site selection, design, layout, construction, renovation, and maintenance of the warehouse meet the storage requirements for
pharmaceutical products;
2) Whether it is equipped with equipment that meets the storage
requirements of pharmaceutical products;
Example: Facilities and equipment that are used for light-proof, ventilation, moisture- proof, insect-proof, rodent-proof, bulk picking, and LCL delivery operations and review. 3) Whether there are work places for receipt and delivery, acceptance
inspection, storage, return, storage of packaging materials, storage of unqualified pharmaceutical products, etc.;
4) When cold chain pharmaceutical products are stored, whether the cold storage complies with the provisions of the relevant chapters of GB/T
28842.
b) For the vehicle, the following contents shall be audited:
1) Whether the compartment is closed and whether the refrigerated vehicle meets the requirements of WB/T 1104;
2) Whether it is equipped with a global positioning system or other
monitoring system.
c) For the refrigerator or incubator, the following contents shall be audited: 1) Whether it is equipped with temperature monitoring equipment;
2) Whether the incubator complies with the regulations of WB/T 1097.
d) For the temperature recorder, the following contents shall be audited: 1) Whether it complies with the provisions of GB/T 35145 and JT/T 1325; 2) Whether the calibration or verification is carried out regularly every year. e) For the information system, the following contents shall be audited: 1) Whether it is equipped with a computer information system that can
operate independently and meet the requirements of the whole process and quality management of pharmaceutical logistics operation, and can
implement the data exchange of the whole process of logistics and the
product traceability and traceable management with the pharmaceutical
logistics service entrusting party;
2) Whether the data entry, modification, storage, and other operations
comply with the scope of authorization, operating procedures, and
management system requirements, and whether the data is original,
authentic, accurate, safe, and traceable;
3) Whether the data storage is safe, reliable, and backed up on a daily basis, and whether the backup data is stored in a safe place;
4) Whether it is equipped with a temperature and humidity monitoring
system capable of real-time automatic monitoring and recording functions, a) The formulation of the internal audit inspection system and internal audit inspection plan, and the record of the internal audit process;
b) Whether the internal audit is carried out regularly or when there are major changes in the key elements of the quality management system, and whether the internal audit situation is analyzed and corresponding improvement
measures are formulated.
6.2.9 For the emergency management, the following contents shall be audited: a) The formulation of the emergency plan management mechanism, the
formulation of emergency plans for possible power outages, equipment
failures, traffic accidents, natural disasters, transportation delays, and other emergencies;
b) Whether the emergency plan includes emergency organization, personnel responsibilities, facilities and equipment, external collaboration resources, response time, emergency measures, etc., and whether the emergency plan is regularly drilled.
7 Audit judgment
Pharmaceutical logistics quality management auditors can conduct the audit judgment on Chapter 6 according to GB/T 28842, GB/T 30335, GB/T 34399, GB/T 35145, JT/T 1325, WB/T 1097, WB/T 1104, or higher standards.
8 Audit results and feedback
8.1 The pharmaceutical logistics quality management auditor shall issue an audit report. The audit report shall include but be not limited to the name of the pharmaceutical logistics service provider, audit time, audit location, audit type and method, audit purpose, audit basis, audit scope, audit team members, audit implementation process, audit contents, audit results, etc.
8.2 When necessary, the pharmaceutical logistics quality management auditor shall notify the pharmaceutical logistics service provider to formulate relevant corrective measures based on the audit results, and check and confirm the corrective results. 9 Evaluation and improvement
9.1 The pharmaceutical logistics quality management auditor shall regularly evaluate the audit work.

View full details